United States Biotechnology & Medical Research

Puma Biotechnology Inc (PBYI)

Track

Over the past 90 days, Puma Biotechnology Inc. insiders have executed 16 transactions, all of which were sales totaling approximately $2.17 million. Key executives, including CEO Alan H. Auerbach and CFO Maximo F. Nougues, participated in these planned and proposed sales. The stock has seen a 6.7% price increase over the same period.
Ticker: PBYI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Puma Biotechnology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 6 Jul 2026
Value US$1,147,248.92 | Price 377.52 | Shares 42,446 (-13.6%)
Proposed sale 6 Jul 2026
Value US$431,435.78 | Price 15.60 | Shares 62,394
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-06 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
42,446 -13.6%
377.52
US$1,147,249 		42,446 -13.6% 377.52 US$1,147,249
2026-07-08 2026-07-06 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
42,563 -38.8%
19.31
US$3,048,559 		42,563 -38.8% 19.31 US$3,048,559
2026-07-08 2026-07-06 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
9,502 -37.3%
333.01
US$81,088 		9,502 -37.3% 333.01 US$81,088
2026-07-06 2026-07-06 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director

Executive Director
44,058
8.26
US$364,042 		44,058 8.26 US$364,042
2026-07-06 2026-07-06 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
8,460
8.26
US$69,903 		8,460 8.26 US$69,903
2026-07-06 2026-07-06 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
9,386
8.26
US$77,555 		9,386 8.26 US$77,555
2026-06-15 2026-06-12 PlS Planned sale
3.0
WILSON TROY EDWARD
Non-Executive Director
10,800 -15.3%
7.20
US$77,748 		10,800 -15.3% 7.20 US$77,748
2026-06-15 2026-06-12 PlS Planned sale
4.1
Stuglik Brian M
Non-Executive Director
8,100 -6.6%
7.20
US$58,311 		8,100 -6.6% 7.20 US$58,311
2026-06-15 2026-06-12 PlS Planned sale
1.6
Senderowicz Adrian
Non-Executive Director
27,000 -50.0%
7.20
US$194,311 		27,000 -50.0% 7.20 US$194,311
2026-06-15 2026-06-12 PlS Planned sale
3.7
MOYES JAY M
Non-Executive Director
22,000 -27.4%
7.22
US$158,796 		22,000 -27.4% 7.22 US$158,796
2026-06-15 2026-06-12 PlS Planned sale
2.5
Dorval Allison
Non-Executive Director
11,610 -11.3%
7.20
US$83,579 		11,610 -11.3% 7.20 US$83,579
2026-06-12 2026-06-12 PrS Proposed sale
1.6
Senderowicz Adrian

Director

Non-Executive Director
27,000
7.26
US$196,020 		27,000 7.26 US$196,020
2026-06-12 2026-06-12 PrS Proposed sale
3.7
MOYES JAY M

Director

Non-Executive Director
22,000
7.26
US$159,720 		22,000 7.26 US$159,720
2026-06-12 2026-06-12 PrS Proposed sale
2.5
Dorval Allison

Director

Non-Executive Director
11,610
7.26
US$84,289 		11,610 7.26 US$84,289
2026-06-12 2026-06-12 PrS Proposed sale
3.0
WILSON TROY EDWARD

Director

Non-Executive Director
10,800
7.26
US$78,408 		10,800 7.26 US$78,408
2026-06-12 2026-06-12 PrS Proposed sale
4.1
Stuglik Brian M

Director

Non-Executive Director
8,100
7.26
US$58,806 		8,100 7.26 US$58,806
2026-01-08 2026-01-07 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
18,012 -0.3%
5.88
US$105,893 		18,012 -0.3% 5.88 US$105,893
2026-01-08 2026-01-07 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
5,014 -3.1%
5.88
US$29,477 		5,014 -3.1% 5.88 US$29,477
2026-01-08 2026-01-07 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
6,405 -3.2%
5.88
US$37,655 		6,405 -3.2% 5.88 US$37,655
2026-01-07 2026-01-07 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director

Executive Director
18,012
5.88
US$105,893 		18,012 5.88 US$105,893
2026-01-07 2026-01-07 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
5,014
5.88
US$29,477 		5,014 5.88 US$29,477
2026-01-07 2026-01-07 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
6,405
5.88
US$37,655 		6,405 5.88 US$37,655
2026-01-08 2026-01-06 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
16,938 -0.2%
5.84
US$98,986 		16,938 -0.2% 5.84 US$98,986
2026-01-08 2026-01-06 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
3,973 -2.4%
5.84
US$23,218 		3,973 -2.4% 5.84 US$23,218
2026-01-08 2026-01-06 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
4,540 -2.2%
5.84
US$26,532 		4,540 -2.2% 5.84 US$26,532
2026-01-06 2026-01-06 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
4,540
5.84
US$26,530 		4,540 5.84 US$26,530
2026-01-06 2026-01-06 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
3,973
5.84
US$23,217 		3,973 5.84 US$23,217
2026-01-06 2026-01-06 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director

Executive Director
16,938
5.84
US$98,979 		16,938 5.84 US$98,979
2025-11-13 2025-11-11 S Sale
2.3
MILLER MICHAEL PATRICK
Non-Executive Director
20,000 -27.0%
4.86
US$97,228 		20,000 -27.0% 4.86 US$97,228
2025-11-12 2025-11-11 PrS Proposed sale
2.3
MILLER MICHAEL PATRICK

Director

Non-Executive Director
20,000
4.86
US$97,228 		20,000 4.86 US$97,228
2025-07-22 2025-07-18 PlS Planned sale
Cesano Alessandra
Non-Executive Director
27,000 -39.2%
3.37
US$90,909 		27,000 -39.2% 3.37 US$90,909
2025-07-18 2025-07-18 PrS Proposed sale
Cesano Alessandra

Director

Non-Executive Director
27,000
3.37
US$90,909 		27,000 3.37 US$90,909
2025-07-10 2025-07-09 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
3,443 -2.0%
3.54
US$12,171 		3,443 -2.0% 3.54 US$12,171
2025-07-10 2025-07-09 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
3,935 -1.9%
3.54
US$13,910 		3,935 -1.9% 3.54 US$13,910
2025-07-10 2025-07-09 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
21,580 -0.3%
3.54
US$76,285 		21,580 -0.3% 3.54 US$76,285
2025-07-09 2025-07-09 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
3,935
3.54
US$13,910 		3,935 3.54 US$13,910
2025-07-09 2025-07-09 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director

Executive Director
21,580
3.54
US$76,285 		21,580 3.54 US$76,285
2025-07-09 2025-07-09 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
3,443
3.54
US$12,171 		3,443 3.54 US$12,171
2025-07-10 2025-07-08 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
4,374 -2.5%
3.53
US$15,453 		4,374 -2.5% 3.53 US$15,453
2025-07-10 2025-07-08 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
5,587 -2.6%
3.53
US$19,739 		5,587 -2.6% 3.53 US$19,739
2025-07-10 2025-07-08 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
25,592 -0.4%
3.53
US$90,417 		25,592 -0.4% 3.53 US$90,417
2025-07-08 2025-07-08 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director

Executive Director
25,592
3.53
US$90,424 		25,592 3.53 US$90,424
2025-07-08 2025-07-08 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
5,587
3.53
US$19,741 		5,587 3.53 US$19,741
2025-07-08 2025-07-08 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
4,374
3.53
US$15,455 		4,374 3.53 US$15,455
2025-06-17 2025-06-13 PlS Planned sale
3.0
WILSON TROY EDWARD
Non-Executive Director
10,800 -19.9%
3.40
US$36,720 		10,800 -19.9% 3.40 US$36,720
2025-06-17 2025-06-13 PlS Planned sale
1.6
Senderowicz Adrian
Non-Executive Director
27,000 -50.0%
3.40
US$91,800 		27,000 -50.0% 3.40 US$91,800
2025-06-17 2025-06-13 PlS Planned sale
4.1
Stuglik Brian M
Non-Executive Director
8,100 -7.9%
3.39
US$27,459 		8,100 -7.9% 3.39 US$27,459
2025-06-17 2025-06-13 PlS Planned sale
3.7
MOYES JAY M
Non-Executive Director
22,000 -29.2%
3.40
US$74,800 		22,000 -29.2% 3.40 US$74,800
2025-06-17 2025-06-13 PlS Planned sale
Cesano Alessandra
Non-Executive Director
12,150 -15.0%
3.40
US$41,310 		12,150 -15.0% 3.40 US$41,310
2025-06-17 2025-06-13 PlS Planned sale
2.5
Dorval Allison
Non-Executive Director
11,610 -13.3%
3.40
US$39,474 		11,610 -13.3% 3.40 US$39,474
2025-06-13 2025-06-13 PrS Proposed sale
3.0
WILSON TROY EDWARD

Director

Non-Executive Director
10,800
3.40
US$36,678 		10,800 3.40 US$36,678
2025-06-13 2025-06-13 PrS Proposed sale
1.6
Senderowicz Adrian

Director

Non-Executive Director
27,000
3.40
US$91,767 		27,000 3.40 US$91,767
2025-06-13 2025-06-13 PrS Proposed sale
2.5
Dorval Allison

Director

Non-Executive Director
11,610
3.40
US$39,437 		11,610 3.40 US$39,437
2025-06-13 2025-06-13 PrS Proposed sale
Cesano Alessandra

Director

Non-Executive Director
12,150
3.40
US$41,285 		12,150 3.40 US$41,285
2025-06-13 2025-06-13 PrS Proposed sale
4.1
Stuglik Brian M

Director

Non-Executive Director
8,100
3.39
US$27,497 		8,100 3.39 US$27,497
2025-06-13 2025-06-13 PrS Proposed sale
3.7
MOYES JAY M

Director

Non-Executive Director
22,000
3.40
US$74,756 		22,000 3.40 US$74,756
2025-05-21 2025-05-21 PrS Proposed sale
3.3
Ludwig Jeffrey Jerome

Former Officer

Officer
55,882
3.42
US$191,310 		55,882 3.42 US$191,310
2025-01-03 2025-01-02 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
10,227 -6.3%
3.15
US$32,232 		10,227 -6.3% 3.15 US$32,232
2025-01-03 2025-01-02 PlS Planned sale
3.3
Ludwig Jeffrey Jerome

Chief Commercial Officer

Officer
9,437 -8.0%
3.15
US$29,743 		9,437 -8.0% 3.15 US$29,743
2025-01-03 2025-01-02 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
8,633 -6.5%
3.15
US$27,209 		8,633 -6.5% 3.15 US$27,209
2025-01-03 2025-01-02 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
33,841 -0.5%
3.15
US$106,657 		33,841 -0.5% 3.15 US$106,657
2025-01-02 2025-01-02 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
10,227
3.05
US$31,192 		10,227 3.05 US$31,192
2025-01-02 2025-01-02 PrS Proposed sale
3.3
Ludwig Jeffrey Jerome

Officer

Officer
9,437
3.05
US$28,783 		9,437 3.05 US$28,783
2025-01-02 2025-01-02 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
8,633
3.05
US$26,331 		8,633 3.05 US$26,331
2025-01-02 2025-01-02 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director; 10% Stockholder

Executive Director Large shareholder
33,841
3.05
US$103,215 		33,841 3.05 US$103,215
2024-08-13 2024-08-12 S Sale
2.3
MILLER MICHAEL PATRICK
Non-Executive Director
23,358 -33.2%
3.49
US$81,466 		23,358 -33.2% 3.49 US$81,466
2024-08-12 2024-08-12 PrS Proposed sale
2.3
MILLER MICHAEL PATRICK

Director

Non-Executive Director
23,358
3.76
US$87,826 		23,358 3.76 US$87,826
2024-07-18 2024-07-17 PlS Planned sale
3.3
Ludwig Jeffrey Jerome

Chief Commercial Officer

Officer
2,598 -2.1%
3.70
US$9,615 		2,598 -2.1% 3.70 US$9,615
2024-07-18 2024-07-17 PlS Planned sale
3.6
NOUGUES MAXIMO F

Chief Financial Officer

Officer
4,156 -2.5%
3.70
US$15,382 		4,156 -2.5% 3.70 US$15,382
2024-07-18 2024-07-17 PlS Planned sale
3.4
AUERBACH ALAN H

President and CEO

Executive Director Large shareholder
21,920 -0.3%
3.70
US$81,128 		21,920 -0.3% 3.70 US$81,128
2024-07-18 2024-07-17 PlS Planned sale
3.6
HUNT DOUGLAS M

See Remarks

Officer
3,637 -2.7%
3.70
US$13,461 		3,637 -2.7% 3.70 US$13,461
2024-07-17 2024-07-17 PrS Proposed sale
3.6
NOUGUES MAXIMO F

Officer

Officer
4,156
3.95
US$16,416 		4,156 3.95 US$16,416
2024-07-17 2024-07-17 PrS Proposed sale
3.3
Ludwig Jeffrey Jerome

Officer

Officer
2,598
3.95
US$10,262 		2,598 3.95 US$10,262
2024-07-17 2024-07-17 PrS Proposed sale
3.6
HUNT DOUGLAS M

Officer

Officer
3,637
3.95
US$14,366 		3,637 3.95 US$14,366
2024-07-17 2024-07-17 PrS Proposed sale
3.4
AUERBACH ALAN H

Officer; Director; 10% Stockholder

Executive Director Large shareholder
21,920
3.95
US$86,584 		21,920 3.95 US$86,584
Explore more

More insider trading research around Puma Biotechnology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America